Recognizing the Signs: Fat Distribution and Red Flags
At a Glance
FPLD5 often causes fat loss in the arms, legs, and buttocks with fat accumulation in the face, neck, upper back, abdomen, or liver. These changes can accompany insulin resistance and very high triglycerides, which raise the risk of acute pancreatitis.
Living with Familial Partial Lipodystrophy Type 5 (FPLD5) means your body follows a unique “blueprint” for where it can and cannot store fat. Because the CIDEC gene mutation affects the ability of fat cells to expand properly, fat is lost in some areas and forced to accumulate in others [1]. Recognizing these physical patterns and their associated “warning signs” is essential for monitoring your metabolic health.
Your Body’s Fat Map
The hallmark of FPLD5 is lipodystrophy, or the selective loss of fat from specific areas of the body. In FPLD5, this pattern is typically peripheral, meaning it affects the outer parts of your body [1]:
- Fat Loss (Lipoatrophy): You may notice a significant loss of fat under the skin of your arms, legs, and the gluteal region (buttocks) [1]. This often gives the limbs a very “muscular” or “lean” appearance, as the muscles become more visible without a cushioning layer of fat [2][3].
- Fat Accumulation: Because the body still needs to store energy, it compensates by depositing fat in “permitted” areas. This often includes the face, neck, and upper back [1]. Unlike some other types of lipodystrophy, such as the more common FPLD2 (Dunnigan Syndrome), FPLD5 usually does not involve the unusual accumulation of fat in the pubic or labial areas [1].
- Internal Storage: Fat may also accumulate inside your abdomen (visceral fat) and within organs like the liver, which cannot be seen from the outside but can be detected via imaging [1].
Signs of Severe Insulin Resistance
When your fat cells cannot store lipids correctly, your body becomes resistant to insulin. This “internal” struggle often creates visible signs on your skin and changes in your hormone levels [1]:
- Acanthosis Nigricans: This appears as dark, “velvety” patches of skin, typically in body folds like the back of the neck, armpits, or groin [1][4]. It suggests that you have underlying insulin resistance, though it is not a direct measurement of your insulin levels.
- Hyperandrogenism (in Women): High insulin levels can trigger the ovaries to produce excess male-pattern hormones. This may lead to hirsutism (excess facial or body hair), acne, and irregular menstrual cycles [1][5].
- Polycystic Ovaries: Women may develop features that overlap with Polycystic Ovary Syndrome (PCOS), though this requires clinical assessment to diagnose properly, and symptoms vary greatly from person to person [6].
High Triglycerides and Skin Changes
If your triglycerides (blood fats) become extremely high, you might notice eruptive xanthomas [7]. These are small, yellowish-red bumps that can appear suddenly, often on the backs of the arms, buttocks, or knees. They are essentially tiny deposits of fat in the skin and serve as a warning that your blood fat levels are severely elevated [8].
Emergency Warning Signs: Acute Pancreatitis
When triglycerides reach very high levels (such as over 500–1,000 mg/dL, which is a significant risk range), they can cause a dangerous inflammation of the pancreas called acute pancreatitis [9][8].
Seek Emergency Care Immediately if you experience:
- Severe abdominal pain that starts suddenly in the upper middle or left side of the belly.
- Pain that feels like it is “boring” through to your back.
- Pain that worsens significantly after eating.
- Severe nausea and vomiting that does not stop.
- A fever or rapid heartbeat accompanying the abdominal pain.
Because FPLD5 carries a higher risk for this condition, any new, persistent, or worsening abdominal discomfort should be discussed with your specialist or assessed urgently [10]. Mild symptoms do not reliably exclude pancreatitis, so clear, severe, and persistent pain should always be treated as a medical emergency.
Common questions in this guide
How does FPLD5 typically change where body fat is stored?
What can dark, velvety skin mean in FPLD5?
Can FPLD5 cause excess hair or irregular menstrual cycles?
What do eruptive xanthomas indicate?
Which abdominal symptoms require emergency care in FPLD5?
How do triglyceride levels affect pancreatitis risk in FPLD5?
Get notified when new evidence is published on CIDEC-related familial partial lipodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.
Patni N, Xing C, Huang CY, et al.
International journal of molecular sciences 2026; (27(2)) doi:10.3390/ijms27020646.
PMID: 41596298 - 2
Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy.
Valerio CM, Viola LF, Guidorizzi NR, et al.
Diabetology & metabolic syndrome 2025; (17(1)):186 doi:10.1186/s13098-025-01733-5.
PMID: 40452043 - 3
Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome.
Lewandowski KC, Lewiński A, Dąbrowska K, et al.
Endokrynologia Polska 2015; (66(6)):550-4 doi:10.5603/EP.2015.0067.
PMID: 26662654 - 4
Acanthosis nigricans as a diagnostic clue for familial partial lipodystrophy type 2: a case report with review of literature on Japanese cases.
Kitamura T, Kusakabe T, Ishihara Y, et al.
Endocrine journal 2026; (73(8)):983-991 doi:10.1507/endocrj.EJ25-0487.
PMID: 42128842 - 5
Familial Partial Lipodystrophy-Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3.
Rutkowska L, Salachna D, Lewandowski K, et al.
Diagnostics (Basel, Switzerland) 2022; (12(5)) doi:10.3390/diagnostics12051122.
PMID: 35626278 - 6
Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects.
Gambineri A, Zanotti L
Nucleus (Austin, Tex.) 2018; (9(1)):392-397 doi:10.1080/19491034.2018.1509659.
PMID: 30131000 - 7
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Chait A, Eckel RH
Annals of internal medicine 2019; (170(9)):626-634 doi:10.7326/M19-0203.
PMID: 31035285 - 8
Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study.
Guidorizzi NR, Valerio CM, Viola LF, et al.
Frontiers in endocrinology 2024; (15()):1359211 doi:10.3389/fendo.2024.1359211.
PMID: 38887266 - 9
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2.
Lazarte J, Wang J, McIntyre AD, Hegele RA
Journal of clinical lipidology 2021; (15(5)):653-657 doi:10.1016/j.jacl.2021.07.004.
PMID: 34340952 - 10
Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.
Besci O, Foss de Freitas MC, Guidorizzi NR, et al.
The Journal of clinical endocrinology and metabolism 2024; (109(3)):e1204-e1224 doi:10.1210/clinem/dgad606.
PMID: 37843397
This page is for informational purposes only and does not constitute medical advice. It explains signs associated with FPLD5, but your clinician must interpret your triglycerides and symptoms; seek emergency care for severe or persistent abdominal pain.